Life Sciences Times

Verastem Oncology Names Michael Bailey CEO as Daniel Paterson Plans Retirement

Zai Lab to Present First Human Trial Data for Experimental Atopic Dermatitis Treatment

Takeda Reports Positive Phase 2/3 Results for Experimental Immunodeficiency Treatment

Akamis Bio Completes Enrollment in Phase 1b Rectal Cancer Treatment Study

MindWalk Strengthens Boston Leadership Team as Drug Development Pipeline Advances

Charles River Laboratories Partners With Magellan Stem Cells to Advance Osteoarthritis Cell Therapy

Butterfly Network Partners With VCOM to Expand Ultrasound Training for Medical Students

Calluna Pharma Completes Dosing in Phase 2 Lung Fibrosis Trial, Expects Results in Early 2027

AcuityMD Launches AI Research Agent to Accelerate Medical Technology Market Analysis

Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies